Skip to content

Prolonged exposure for PTSD

TL;DR — Prolonged exposure (PE) is a manualized trauma-focused therapy with strong efficacy evidence. Across 65 exposure-therapy articles (n=4,929), exposure showed large effects versus waitlist/usual care, small effects versus non-trauma-focused comparators and negligible differences versus other trauma-focused therapies or medication (McLean 2022, PMID 34954460). The interpretive issue is therefore not whether PE can work, but comparative benefit, completion, delivery burden and who is represented. Routine-care dropout can be 38–51%; in the largest randomized CPT-versus-PE comparison to date (n=916 US veterans), dropout was higher in PE (52.31%) than CPT (45.77%), with the difference emerging after session 3 (Harper 2026, PMID 41926191).

Components

PE combines psychoeducation, breathing or grounding as needed, repeated imaginal recounting/processing, in-vivo approach to avoided safe situations and between-session practice. Exposure is planned learning, not uncontrolled re-traumatisation.

Effect size depends on comparator

Waitlist comparisons estimate treatment plus attention/expectancy/time; active comparisons isolate less. The shift from large to negligible effects across comparator classes is central (McLean 2022, PMID 34954460).

Mechanism

Habituation is observable but not required as the sole mechanism. The inhibitory-learning account holds that extinction adds a new inhibitory association rather than erasing the original one, and proposes eight optimization strategies — expectancy violation, deepened extinction, occasional reinforced extinction, removal of safety signals, variability, retrieval cues, multiple contexts and affect labeling — explicitly distinguished from a fear-habituation approach (Craske 2014, PMID 24864005). Human neurocircuitry work on extinction and its retrieval supplies the amygdala–medial prefrontal–hippocampal framework these models are stated in, but imaging models do not by themselves adjudicate between mechanisms (Shin 2006, PMID 16891563) (Rauch 2006, PMID 16919525).

Safety

Temporary distress is expected; trials rarely reported adverse events consistently, which prevents precise risk estimates (Cusack 2016, PMID 26574151). Active suicide risk, severe dissociation, intoxication/withdrawal and unsafe environments require assessment, but comorbidity alone is not proof that PE is contraindicated (Coventry 2020, PMID 32813696).

Delivery

Massed, telehealth, primary-care and digitally supported formats trade intensity, access and monitoring, and the compression question has been tested directly. In 370 randomized active-duty personnel, massed PE (10 sessions over 2 weeks) reduced PSS-I severity more than minimal-contact control at 2 weeks (difference in decrease 3.70, 95% CI 0.72–6.68; P=.02) and was noninferior to spaced PE over 8 weeks (difference 0.79, 1-sided 95% CI upper bound 2.29; P=.049 for noninferiority), while spaced PE did not differ from present-centred therapy (Foa 2018, PMID 29362795). A 138-participant military/veteran noninferiority trial found massed PE non-inferior to standard PE (between-group difference 0.94, 95% CI −4.19 to +6.07, upper bound below the +7 margin), with loss of PTSD diagnosis in 53.8% versus 54.1% and dropout of 4.8% versus 16.9% (Dell 2023, PMID 35440345). Across 35 RCTs (n=1,508), prescribing PE at least twice weekly was associated with dropout of 21.0% (95% CI 13.9–30.4) versus 34.0% (95% CI 28.9–39.4) at lower frequency (OR 0.52, 95% CI 0.30–0.89, P=.018), though only one RCT compared frequencies head to head (Levinson 2022, PMID 35278229). Non-inferiority claims of this kind require prespecified margins and retention, not only within-arm improvement; a seven-study review comparing psychotherapy and medication found three trials in which psychotherapy was superior to SSRIs, two showing an augmenting effect with prolonged exposure and two showing no between-group difference, with psychotherapy patients more likely to drop out in four of the seven, and concluded the evidence is insufficient to judge combined therapy (Storm 2021, PMID 34477098).

Population transport

Effects were larger in civilian/refugee than military samples and varied with SUD and medication composition in meta-regression; these are study-level associations, not patient-selection rules (McLean 2022, PMID 34954460).

Quantitative anchors

Measure Estimate Population/method Source
Exposure meta-analysis 65 articles; n=4,929 Large vs waitlist/TAU; negligible vs other TF therapy/medication (McLean 2022, PMID 34954460)
Manualized therapies review 114 RCTs; n=8,171 PE among strongest-evidence CBT-Ts (Lewis 2020, PMID 32284821)
AHRQ-era review 64 trials Exposure high strength of evidence; NNT <4 for loss of diagnosis (Cusack 2016, PMID 26574151)
PE vs CPT dropout study n=916 veterans PE 52.31% vs CPT 45.77% dropout; routine care 38–51% (Harper 2026, PMID 41926191)
Massed vs spaced PE noninferior; massed > minimal-contact control by 3.70 (95% CI 0.72–6.68) 370 active-duty personnel (Foa 2018, PMID 29362795)
Massed vs standard PE difference 0.94 (95% CI −4.19 to 6.07); dropout 4.8% vs 16.9% 138 military/veterans (Dell 2023, PMID 35440345)
PE ≥2 sessions/week dropout 21.0% vs 34.0% (OR 0.52, 95% CI 0.30–0.89) 35 RCTs; n=1,508 (Levinson 2022, PMID 35278229)

Evidence ledger

The ledger lists the live-retrieved records used to bound this page. Inclusion does not make every record equally probative; design, population and comparator remain decisive.

PMID Year Evidence contribution Scope caution
32063234 2020 Psychological treatments for post-traumatic stress disorder in adults: a network meta-analysis. Synthesis: preserve included-population and certainty limits
32284821 2020 Psychological therapies for post-traumatic stress disorder in adults: systematic review and meta-analysis. Synthesis: preserve included-population and certainty limits
26574151 2016 Psychological treatments for adults with posttraumatic stress disorder: A systematic review and meta-analysis. Synthesis: preserve included-population and certainty limits
34954460 2022 Exposure therapy for PTSD: A meta-analysis. Synthesis: preserve included-population and certainty limits
32813696 2020 Psychological and pharmacological interventions for posttraumatic stress disorder and comorbid mental health problems following complex traumatic events: Systematic review and component network meta-analysis. Synthesis: preserve included-population and certainty limits
29451967 2018 Cognitive behavioral therapy for anxiety and related disorders: A meta-analysis of randomized placebo-controlled trials. Synthesis: preserve included-population and certainty limits
34473342 2022 Trauma-focused psychotherapies for post-traumatic stress disorder: A systematic review and network meta-analysis. Synthesis: preserve included-population and certainty limits
37141033 2023 The efficacy and acceptability of psychological interventions for adult PTSD: A network and pairwise meta-analysis of randomized controlled trials. Synthesis: preserve included-population and certainty limits
37971855 2024 Project harmony: A systematic review and network meta-analysis of psychotherapy and pharmacologic trials for comorbid posttraumatic stress, alcohol, and other drug use disorders. Synthesis: preserve included-population and certainty limits
32924926 2020 Interventions for adults with a history of complex traumatic events: the INCiTE mixed-methods systematic review. Synthesis: preserve included-population and certainty limits
40001042 2025 Mind-body intervention for post-traumatic stress disorder in adolescents: a systematic review and network meta-analysis. Synthesis: preserve included-population and certainty limits
40476517 2025 Efficacy of psychosocial interventions on social functioning in individuals with childhood maltreatment experiences: a protocol for a systematic review and network meta-analysis. Synthesis: preserve included-population and certainty limits
31313834 2020 Research Review: Psychological and psychosocial treatments for children and young people with post-traumatic stress disorder: a network meta-analysis. Synthesis: preserve included-population and certainty limits
34599050 2021 Comparative efficacy and acceptability of psychotherapies for post-traumatic stress disorder in children and adolescents: a systematic review and network meta-analysis. Synthesis: preserve included-population and certainty limits
32353011 2020 Cost-effectiveness of psychological treatments for post-traumatic stress disorder in adults. PTSD-specific record; inspect design and population
31654414 2020 Cost-effectiveness of psychological interventions for children and young people with post-traumatic stress disorder. PTSD-specific record; inspect design and population
20546985 2010 A meta-analytic review of prolonged exposure for posttraumatic stress disorder. Synthesis: preserve included-population and certainty limits
35278229 2022 Less dropout from prolonged exposure sessions prescribed at least twice weekly: A meta-analysis and systematic review of randomized controlled trials. Synthesis: preserve included-population and certainty limits
20614457 2010 Combined pharmacotherapy and psychological therapies for post traumatic stress disorder (PTSD). PTSD-specific record; inspect design and population
24382682 2014 Primum non nocere (first do no harm): symptom worsening and improvement in female assault victims after prolonged exposure for PTSD. PTSD-specific record; inspect design and population
34477098 2021 Comparing treatments for post-traumatic stress disorder - a systematic review. Synthesis: preserve included-population and certainty limits
36628572 2023 Comparative effectiveness of psychotherapies in adults with posttraumatic stress disorder: a network meta-analysis of randomised controlled trials. Synthesis: preserve included-population and certainty limits
35413848 2022 The efficacy and acceptability of exposure therapy for the treatment of post-traumatic stress disorder in children and adolescents: a systematic review and meta-analysis. Synthesis: preserve included-population and certainty limits
31690461 2019 Medication versus trauma-focused psychotherapy for adults with posttraumatic stress disorder: A systematic review and meta-analysis. Synthesis: preserve included-population and certainty limits
41926191 2026 Comparing dropout from cognitive processing therapy versus prolonged exposure: Results from a randomized clinical trial. PTSD-specific record; inspect design and population
16891563 2006 Amygdala, medial prefrontal cortex, and hippocampal function in PTSD. PTSD-specific record; inspect design and population
16919525 2006 Neurocircuitry models of posttraumatic stress disorder and extinction: human neuroimaging research--past, present, and future. PTSD-specific record; inspect design and population
38590124 2024 Cognitive-behavioural conjoint therapy versus prolonged exposure for PTSD in military service members and veterans: results and lessons from a randomized controlled trial. PTSD-specific record; inspect design and population
24864005 2014 Maximizing exposure therapy: an inhibitory learning approach. Mechanistic framework across anxiety disorders; not a PTSD efficacy estimate
29362795 2018 Effect of Prolonged Exposure Therapy Delivered Over 2 Weeks vs 8 Weeks vs Present-Centered Therapy on PTSD Symptom Severity in Military Personnel: A Randomized Clinical Trial. PTSD-specific record; inspect design and population
35440345 2023 Effect of massed v. standard prolonged exposure therapy on PTSD in military personnel and veterans: a non-inferiority randomised controlled trial. PTSD-specific record; inspect noninferiority margin
## Interpretation guardrails
  • Trauma exposure, post-traumatic symptoms, acute stress disorder, DSM-5 PTSD, ICD-11 PTSD and ICD-11 complex PTSD are not interchangeable populations.
  • A mixed-anxiety or transdiagnostic estimate is labelled as such; only a source’s PTSD stratum can be treated as a PTSD effect.
  • Comorbid depression is measured separately and cross-linked to the depression condition; it is not absorbed into PTSD.
  • Waitlist, treatment-as-usual, attention control and active treatment answer different causal questions.
  • Registration, statistical significance and diagnostic loss do not respectively prove completion, clinical importance or functional recovery.
  • This page synthesizes research and does not provide individual medical advice.

Minimum extraction frame for studies on this topic

Field What must be retained Why it changes interpretation
Diagnostic system DSM version, ICD version, full/subthreshold Case mix is not interchangeable
Diagnostic method Structured interview, clinician judgment, self-report cutoff Screening is not diagnosis
Index trauma Type, timing, repetition, direct/indirect/occupational Conditional risk and phenotype differ
Population Civilian, veteran, refugee, child/adolescent, mixed Transportability is empirical
Baseline severity Mean, SD, range and exclusion threshold Ceiling and floor effects alter change
CPTSD status ITQ/ICD-11 definition and DSO score Complexity cannot be inferred from trauma count
Comorbidity Depression, GAD, SUD, pain, TBI measured separately Shared symptoms can distort effects
Comparator Waitlist, usual care, attention, active treatment The estimand changes with comparator
Treatment dose Sessions offered/attended, duration, homework Assignment is not exposure
Outcome Symptoms, diagnosis, response, function, sleep Outcomes are not interchangeable
Time point End point and prespecified follow-up windows Acute benefit may not persist
Missing data Denominator, reasons, imputation and estimand Attrition can bias rank and magnitude
Adverse events Definitions, ascertainment and arm-level counts Absence of reporting is not absence of harm
Therapist/context Training, fidelity, allegiance, setting Delivery is part of the intervention
Funding/conflicts Sponsor role and analytic independence Especially material for proprietary packages

Claims this page does not make

  • It does not infer PTSD from trauma exposure alone.
  • It does not treat a self-report cutoff as equivalent to a structured diagnosis.
  • It does not convert a pooled anxiety-disorder effect into a PTSD effect.
  • It does not convert a depression outcome in a comorbid sample into a PTSD outcome.
  • It does not infer superiority from a statistically significant within-group change.
  • It does not infer equivalence from a non-significant between-group test.
  • It does not infer effectiveness from trial registration or mechanistic plausibility.
  • It does not assume military, civilian, refugee and pediatric estimates transport unchanged.
  • It does not average conflicting estimates that use different definitions.
  • It does not treat lack of adverse-event reporting as evidence of safety.

Evidence-updating triggers

Trigger Required response
New diagnostic revision Recalculate which populations prior estimates represent
New head-to-head RCT Compare against active treatment, not only waitlist
New individual-participant synthesis Revisit effect modifiers and transportability
Registry status change Verify results and linked publication before changing conclusions
Guideline update Separate evidence review from panel recommendation
Regulatory decision Record decision date and source; do not infer from efficacy papers
Safety signal Re-extract denominator, ascertainment and exposure time by arm
Contradictory replication Display estimates side by side; do not average definitions

Evidence updates should preserve the prior estimate and explain why the new study changes—or does not change—the inference.

Open questions

  • What retention-adjusted estimand best represents PE benefit in routine care? (Harper 2026, PMID 41926191) (Carpenter 2018, PMID 29451967)
  • Which learning markers mediate PE response rather than merely correlate with symptom change? (Shin 2006, PMID 16891563)
  • Do massed and weekly PE have equivalent durable effects and adverse-event profiles? (Storm 2021, PMID 34477098)

References

  1. Mavranezouli I, et al. Psychological treatments for post-traumatic stress disorder in adults: a network meta-analysis. Psychol Med. 2020;50(4):542-555. PMID 32063234
  2. Lewis C, et al. Psychological therapies for post-traumatic stress disorder in adults: systematic review and meta-analysis. Eur J Psychotraumatol. 2020;11(1):1729633. PMID 32284821
  3. Cusack K, et al. Psychological treatments for adults with posttraumatic stress disorder: A systematic review and meta-analysis. Clin Psychol Rev. 2016;43:128-41. PMID 26574151
  4. McLean CP, et al. Exposure therapy for PTSD: A meta-analysis. Clin Psychol Rev. 2022;91:102115. PMID 34954460
  5. Coventry PA, et al. Psychological and pharmacological interventions for posttraumatic stress disorder and comorbid mental health problems following complex traumatic events: Systematic review and component network meta-analysis. PLoS Med. 2020;17(8):e1003262. PMID 32813696
  6. Carpenter JK, et al. Cognitive behavioral therapy for anxiety and related disorders: A meta-analysis of randomized placebo-controlled trials. Depress Anxiety. 2018;35(6):502-514. PMID 29451967
  7. Jericho B, et al. Trauma-focused psychotherapies for post-traumatic stress disorder: A systematic review and network meta-analysis. Acta Psychiatr Scand. 2022;145(2):132-155. PMID 34473342
  8. Hoppen TH, et al. The efficacy and acceptability of psychological interventions for adult PTSD: A network and pairwise meta-analysis of randomized controlled trials. J Consult Clin Psychol. 2023;91(8):445-461. PMID 37141033
  9. Hien DA, et al. Project harmony: A systematic review and network meta-analysis of psychotherapy and pharmacologic trials for comorbid posttraumatic stress, alcohol, and other drug use disorders. Psychol Bull. 2024;150(3):319-353. PMID 37971855
  10. Melton H, et al. Interventions for adults with a history of complex traumatic events: the INCiTE mixed-methods systematic review. Health Technol Assess. 2020;24(43):1-312. PMID 32924926
  11. Bianjiang Z, et al. Mind-body intervention for post-traumatic stress disorder in adolescents: a systematic review and network meta-analysis. BMC Psychiatry. 2025;25(1):178. PMID 40001042
  12. Fares-Otero NE, et al. Efficacy of psychosocial interventions on social functioning in individuals with childhood maltreatment experiences: a protocol for a systematic review and network meta-analysis. Eur J Psychotraumatol. 2025;16(1):2508548. PMID 40476517
  13. Mavranezouli I, et al. Research Review: Psychological and psychosocial treatments for children and young people with post-traumatic stress disorder: a network meta-analysis. J Child Psychol Psychiatry. 2020;61(1):18-29. PMID 31313834
  14. Xiang Y, et al. Comparative efficacy and acceptability of psychotherapies for post-traumatic stress disorder in children and adolescents: a systematic review and network meta-analysis. Evid Based Ment Health. 2021;24(4):153-160. PMID 34599050
  15. Mavranezouli I, et al. Cost-effectiveness of psychological treatments for post-traumatic stress disorder in adults. PLoS One. 2020;15(4):e0232245. PMID 32353011
  16. Mavranezouli I, et al. Cost-effectiveness of psychological interventions for children and young people with post-traumatic stress disorder. J Child Psychol Psychiatry. 2020;61(6):699-710. PMID 31654414
  17. Powers MB, et al. A meta-analytic review of prolonged exposure for posttraumatic stress disorder. Clin Psychol Rev. 2010;30(6):635-41. PMID 20546985
  18. Levinson DB, et al. Less dropout from prolonged exposure sessions prescribed at least twice weekly: A meta-analysis and systematic review of randomized controlled trials. J Trauma Stress. 2022;35(4):1047-1059. PMID 35278229
  19. Hetrick SE, et al. Combined pharmacotherapy and psychological therapies for post traumatic stress disorder (PTSD). Cochrane Database Syst Rev. 2010;2010(7):CD007316. PMID 20614457
  20. Jayawickreme N, et al. Primum non nocere (first do no harm): symptom worsening and improvement in female assault victims after prolonged exposure for PTSD. Depress Anxiety. 2014;31(5):412-9. PMID 24382682
  21. Storm MP, et al. Comparing treatments for post-traumatic stress disorder - a systematic review. Dan Med J. 2021;68(9):A09200643. PMID 34477098
  22. Yunitri N, et al. Comparative effectiveness of psychotherapies in adults with posttraumatic stress disorder: a network meta-analysis of randomised controlled trials. Psychol Med. 2023;53(13):6376-6388. PMID 36628572
  23. Huang T, et al. The efficacy and acceptability of exposure therapy for the treatment of post-traumatic stress disorder in children and adolescents: a systematic review and meta-analysis. BMC Psychiatry. 2022;22(1):259. PMID 35413848
  24. Sonis J, et al. Medication versus trauma-focused psychotherapy for adults with posttraumatic stress disorder: A systematic review and meta-analysis. Psychiatry Res. 2019;282:112637. PMID 31690461
  25. Harper KL, et al. Comparing dropout from cognitive processing therapy versus prolonged exposure: Results from a randomized clinical trial. J Consult Clin Psychol. 2026;94(3):140-150. PMID 41926191
  26. Shin LM, et al. Amygdala, medial prefrontal cortex, and hippocampal function in PTSD. Ann N Y Acad Sci. 2006;1071:67-79. PMID 16891563
  27. Rauch SL, et al. Neurocircuitry models of posttraumatic stress disorder and extinction: human neuroimaging research--past, present, and future. Biol Psychiatry. 2006;60(4):376-82. PMID 16919525
  28. Monson CM, et al. Cognitive-behavioural conjoint therapy versus prolonged exposure for PTSD in military service members and veterans: results and lessons from a randomized controlled trial. Eur J Psychotraumatol. 2024;15(1):2330305. PMID 38590124
  29. Craske MG, et al. Maximizing exposure therapy: an inhibitory learning approach. Behav Res Ther. 2014;58:10-23. PMID 24864005
  30. Foa EB, et al. Effect of Prolonged Exposure Therapy Delivered Over 2 Weeks vs 8 Weeks vs Present-Centered Therapy on PTSD Symptom Severity in Military Personnel: A Randomized Clinical Trial. JAMA. 2018;319(4):354-364. PMID 29362795
  31. Dell L, et al. Effect of massed v. standard prolonged exposure therapy on PTSD in military personnel and veterans: a non-inferiority randomised controlled trial. Psychol Med. 2023;53(9):4192-4199. PMID 35440345